LEUVEN, Belgium, March 11, 2014 (GLOBE NEWSWIRE) -- TiGenix NV (Euronext Brussels: TIG), the European leader in cell therapy, gives an update of its business activities and announces financial results for the full year 2013.
Help employers find you! Check out all the jobs and post your resume.
